title: The chronic spleen injury of mice following long-term exposure to titanium dioxide nanoparticles.
abstract: To understand the chronic spleen injury induced by intragastric administrations with 2.5, 5, and 10 mg kg(-1) body weight titanium dioxide nanoparticles (TiO(2) NPs) for 90 consecutive days, histopathological and ultrastructure changes, hematological parameters, lymphocyte subsets, the inflammatory, and apoptotic cytokines in the mouse spleen were investigated. Our findings indicate that TiO(2) NPs exposure results in the significant increase in the spleen indices, histopathological changes, and splenocyte apoptosis in spleen. Especially, in these TiO(2) NPs-treated mice, immunoglobulin, blood cells, platelets, hemoglobin, lymphocyte subsets (such as CD3, CD4, CD8, B cell, natural killer cell) of mice were significantly decreased. Furthermore, TiO(2) NPs exposure can significantly increase the levels of nucleic factor-κB, tumor necrosis factor-α, macrophage migration inhibitory factor, interleukin-2, interleukin-4, interleukin-6, interleukin-8, interleukin-10, interleukin-18, interleukin-1β, cross-reaction protein, transforming growth factor-β, interferon-γ, Bax, and CYP1A1 expression, whereas decrease the levels of Bcl-2 and heat shock protein 70 expression. These findings suggest that long-term exposure to low dose TiO(2) NPs may result in spleen injury and reduction of immune capacity, TiO(2) NP-induced injury in spleen may result from alteration of inflammatory and apoptotic cytokines expression, and workers and consumers should take great caution when handling nanomaterials.
authors.affiliation: Medical College of Soochow University, Suzhou 215123, People's Republic of China.
authors.forename: Xuezi
authors.initials: X
authors.lastname: Sang
authors.forename: Lei
authors.initials: L
authors.lastname: Zheng
authors.forename: Qingqing
authors.initials: Q
authors.lastname: Sun
authors.forename: Na
authors.initials: N
authors.lastname: Li
authors.forename: Yaling
authors.initials: Y
authors.lastname: Cui
authors.forename: Renping
authors.initials: R
authors.lastname: Hu
authors.forename: Guodong
authors.initials: G
authors.lastname: Gao
authors.forename: Zhe
authors.initials: Z
authors.lastname: Cheng
authors.forename: Jie
authors.initials: J
authors.lastname: Cheng
authors.forename: Suxin
authors.initials: S
authors.lastname: Gui
authors.forename: Huiting
authors.initials: H
authors.lastname: Liu
authors.forename: Zengli
authors.initials: Z
authors.lastname: Zhang
authors.forename: Fashui
authors.initials: F
authors.lastname: Hong
mesh_terms: D000818:Animals; D002908:Chronic Disease; D008297:Male; D053768:Metal Nanoparticles; D051379:Mice; D008813:Mice, Inbred ICR; D013154:Spleen / Q000293:injuries*; D014025:Titanium / Q000008:administration & dosage*
chemical_list: C009495:titanium dioxide; D014025:Titanium